Latest CCL2 Stories
Stem cells have the unique ability to become any type of cell in the body.
Researchers at Rush University Medical Center, in collaboration with researchers at Northwestern University, have identified a molecular mechanism central to the development of osteoarthritis (OA) pain, a finding that could have major implications for future treatment of this often-debilitating condition.
Amyotrophic lateral sclerosis (ALS) is a progressive disease wherein the cells of the central nervous system (CNS) involved in movement and coordination are destroyed.
It is not primary tumors that are responsible for the majority of cancer deaths, but rather their metastases.
Potential new treatment for metastatic colon cancer
Tumors are equipped with many tricks to help them sidestep the immune system. This study reveals a new trick- the ability to keep tumor-fighting T cells out by disabling a T cell-attracting protein within the tumor core.
Tumors have an arsenal of tricks to help them sidestep the immune system.
Malignant melanoma is a highly aggressive and notoriously chemoresistant form of cancer.
MOUNTAIN VIEW, Calif., Sept. 21 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD).
MOUNTAIN VIEW, Calif., March 22 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.